Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration has cleared DxnA's GeneSTAT.MDx Coccidioides test for valley fever, the company announced on Wednesday.

The test was cleared to run on the PCR-based GeneSTAT system and is intended for the rapid detection of Coccidioidomycosis. It can provide a definitive diagnosis for both Coccidioides strains that cause the infection and was developed based on intellectual property exclusively licensed from the Translational Genomics Research Institute and the Northern Arizona University.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.